CREST: phase III study of sasanlimab and Bacillus Calmette-Guérin for patients with Bacillus Calmette-Guérin-naïve high-risk non-muscle-invasive bladder cancer

Steinberg, Gary D.; Shore, Neal D.; Redorta, Joan Palou; Galsky, Matthew D.; Bedke, Jens; Ku, Ja Hyeon; Kretkowski, Michal; Hu, Hailong; Penkov, Konstantin; Vermette, Jennifer J.; Tarazi, Jamal C.; Randall, Alison E.; Pierce, Kristen J.; Saltzstein, Daniel; Powles, Thomas B.

dc.contributor.author	Bedke, Jens
dc.date.accessioned	2024-07-29T08:10:40Z
dc.date.available	2024-07-29T08:10:40Z
dc.date.issued	2024
dc.identifier.issn	1479-6694
dc.identifier.uri	http://hdl.handle.net/10900/155843
dc.language.iso	en	de_DE
dc.publisher	London : Future Medicine Ltd	de_DE
dc.relation.uri	http://dx.doi.org/10.2217/fon-2023-0271	de_DE
dc.subject.ddc	610	de_DE
dc.title	CREST: phase III study of sasanlimab and Bacillus Calmette-Guérin for patients with Bacillus Calmette-Guérin-naïve high-risk non-muscle-invasive bladder cancer	de_DE
dc.type	Article	de_DE
utue.quellen.id	20240422000000_00982
utue.publikation.seiten	891-901	de_DE
utue.personen.roh	Steinberg, Gary D.
utue.personen.roh	Shore, Neal D.
utue.personen.roh	Redorta, Joan Palou
utue.personen.roh	Galsky, Matthew D.
utue.personen.roh	Bedke, Jens
utue.personen.roh	Ku, Ja Hyeon
utue.personen.roh	Kretkowski, Michal
utue.personen.roh	Hu, Hailong
utue.personen.roh	Penkov, Konstantin
utue.personen.roh	Vermette, Jennifer J.
utue.personen.roh	Tarazi, Jamal C.
utue.personen.roh	Randall, Alison E.
utue.personen.roh	Pierce, Kristen J.
utue.personen.roh	Saltzstein, Daniel
utue.personen.roh	Powles, Thomas B.
dcterms.isPartOf.ZSTitelID	Future Oncology	de_DE
dcterms.isPartOf.ZS-Issue	14	de_DE
dcterms.isPartOf.ZS-Volume	20	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE